InflaRx

-$0.08 (-2.54%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell InflaRx and other stocks, options, and ETFs commission-free!

About IFRX

InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a.

CEO
Niels Christoph Riedemann
Employees
49
Headquarters
Jena, Thueringen
Founded
2007

IFRX Key Statistics

Market Cap
134.58M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
277.46K
High Today
$3.21
Low Today
$3.05
Open Price
$3.15
Volume
216.54K
52 Week High
$7.46
52 Week Low
$2.66

IFRX Earnings

-$0.61
-$0.41
-$0.20
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure